FDA panel backs previously rejected obesity pill
Published 02/22/2012, The Jamestown Sun
SILVER SPRING, Md. (AP) — A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a decade.Word count: 950
The full article is available to newspaper subscribers. If you are a subscriber please log in to continue reading.